Home
/
NEUROONE MEDICAL TECHNOLOGIES Corp
/
Financials
/
Quarterly
NEUROONE MEDICAL TECHNOLOGIES Corp — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that NEUROONE MEDICAL TECHNOLOGIES Corp filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2026
Dec 31, 2025
$2.89M
Feb 17, 2026
Q3
2025
Jun 30, 2025
$1.70M
Aug 14, 2025
Q2
2025
Mar 31, 2025
$1.39M
May 13, 2025
Q1
2026
Dec 31, 2024
$3.27M
Feb 17, 2026
Q3
2025
Jun 30, 2024
$825.8K
Aug 14, 2025
Q2
2025
Mar 31, 2024
$1.38M
May 13, 2025
Q1
2025
Dec 31, 2023
$977.6K
Feb 12, 2025
Q3
2024
Jun 30, 2023
$629.9K
Aug 14, 2024
Q2
2024
Mar 31, 2023
$466.2K
May 14, 2024
Q1
2024
Dec 31, 2022
$114.6K
Feb 13, 2024
Q3
2023
Jun 30, 2022
$32.0K
Aug 14, 2023
Q1
2022
Mar 31, 2022
$36.6K
May 12, 2022
Q2
2023
Mar 31, 2022
$36.6K
May 12, 2023
Q1
2023
Dec 31, 2021
$33.7K
Feb 13, 2023
Q3
2022
Jun 30, 2021
$40.1K
Aug 11, 2022
Q2
2021
Mar 31, 2021
$18.2K
May 14, 2021
Q1
2022
Mar 31, 2021
$18.2K
May 12, 2022
Q1
2022
Dec 31, 2020
$71.5K
Feb 14, 2022
Q1
2013
Mar 31, 2013
$406
May 15, 2013
Q3
2012
Sep 30, 2012
$23
Nov 13, 2012
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2017
Jun 30, 2017
$0
Aug 14, 2017
Q1
2017
Mar 31, 2017
$0
May 22, 2017
Q3
2016
Sep 30, 2016
$0
Nov 21, 2016
Q2
2017
Jun 30, 2016
$0
Aug 14, 2017
Q1
2017
Mar 31, 2016
$0
May 22, 2017
Q3
2016
Sep 30, 2015
$0
Nov 21, 2016
Q2
2016
Jun 30, 2015
$0
Aug 19, 2016
Q1
2016
Mar 31, 2015
$113
May 23, 2016
Q3
2015
Sep 30, 2014
$139
Nov 16, 2015
Q2
2015
Jun 30, 2014
$303
Aug 13, 2015
Q1
2015
Mar 31, 2014
$165
May 20, 2015
Q3
2014
Sep 30, 2013
$252
Nov 19, 2014
Q2
2014
Jun 30, 2013
$451
Aug 18, 2014
Q1
2014
Mar 31, 2013
$406
May 20, 2014
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2026
Dec 31, 2025
($1.44M)
Feb 17, 2026
Q3
2025
Jun 30, 2025
($1.50M)
Aug 14, 2025
Q2
2025
Mar 31, 2025
($2.27M)
May 13, 2025
Q3
2025
Mar 31, 2025
($2.27M)
Aug 14, 2025
Q3
2025
Dec 31, 2024
$1.79M
Aug 14, 2025
Q2
2025
Dec 31, 2024
$1.79M
May 13, 2025
Q1
2026
Dec 31, 2024
$1.79M
Feb 17, 2026
Q3
2025
Jun 30, 2024
($2.77M)
Aug 14, 2025
Q3
2025
Mar 31, 2024
($2.86M)
Aug 14, 2025
Q2
2025
Mar 31, 2024
($2.86M)
May 13, 2025
Q2
2025
Dec 31, 2023
($3.34M)
May 13, 2025
Q3
2025
Dec 31, 2023
($3.34M)
Aug 14, 2025
Q1
2025
Dec 31, 2023
($3.34M)
Feb 12, 2025
Q3
2024
Jun 30, 2023
($3.47M)
Aug 14, 2024
Q2
2024
Mar 31, 2023
($3.52M)
May 14, 2024
Q3
2024
Mar 31, 2023
($3.52M)
Aug 14, 2024
Q1
2024
Dec 31, 2022
($1.73M)
Feb 13, 2024
Q3
2024
Dec 31, 2022
($1.73M)
Aug 14, 2024
Q2
2024
Dec 31, 2022
($1.73M)
May 14, 2024
Q3
2023
Jun 30, 2022
($2.76M)
Aug 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2026
Dec 31, 2025
($1.71M)
Feb 17, 2026
Q3
2025
Jun 30, 2025
($1.89M)
Aug 14, 2025
Q2
2025
Mar 31, 2025
($2.68M)
May 13, 2025
Q1
2026
Dec 31, 2024
$1.71M
Feb 17, 2026
Q3
2025
Jun 30, 2024
($2.79M)
Aug 14, 2025
Q2
2025
Mar 31, 2024
($2.89M)
May 13, 2025
Q1
2025
Dec 31, 2023
($3.39M)
Feb 12, 2025
Q3
2024
Jun 30, 2023
($3.51M)
Aug 14, 2024
Q2
2024
Mar 31, 2023
($3.50M)
May 14, 2024
Q1
2024
Dec 31, 2022
($1.78M)
Feb 13, 2024
Q3
2023
Jun 30, 2022
($2.76M)
Aug 14, 2023
Q2
2023
Mar 31, 2022
($3.06M)
May 12, 2023
Q1
2022
Mar 31, 2022
($3.06M)
May 12, 2022
Q1
2023
Dec 31, 2021
($2.81M)
Feb 13, 2023
Q3
2022
Jun 30, 2021
($3.03M)
Aug 11, 2022
Q2
2021
Mar 31, 2021
($2.40M)
May 14, 2021
Q1
2022
Mar 31, 2021
($2.40M)
May 12, 2022
Q1
2022
Dec 31, 2020
($2.14M)
Feb 14, 2022
Q3
2021
Jun 30, 2020
($1.59M)
Aug 13, 2021
Q2
2021
Mar 31, 2020
($1.38M)
May 14, 2021